148 related articles for article (PubMed ID: 1397026)
1. Acetyl-L-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study.
Harsing LG; Sershen H; Toth E; Hashim A; Ramacci MT; Lajtha A
Eur J Pharmacol; 1992 Jul; 218(1):117-21. PubMed ID: 1397026
[TBL] [Abstract][Full Text] [Related]
2. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
4. L-dopa administration enhances exocytotic dopamine release in vivo in the rat striatum.
Koshimura K; Ohue T; Akiyama Y; Itoh A; Miwa S
Life Sci; 1992; 51(10):747-55. PubMed ID: 1325018
[TBL] [Abstract][Full Text] [Related]
5. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.
Imperato A; Di Chiara G
J Neurosci; 1984 Apr; 4(4):966-77. PubMed ID: 6716134
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
Robertson GS; Damsma G; Fibiger HC
J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
[TBL] [Abstract][Full Text] [Related]
7. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
[TBL] [Abstract][Full Text] [Related]
8. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
9. Cyclo (His-Pro), d-amphetamine and striatal dopamine: a microdialysis study.
Levy A; Stillman MJ; Rauch TM
Brain Res Bull; 1991 Jul; 27(1):129-31. PubMed ID: 1933425
[TBL] [Abstract][Full Text] [Related]
10. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.
Janhunen S; Mielikäinen P; Paldánius P; Tuominen RK; Ahtee L; Kaakkola S
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):480-91. PubMed ID: 16012872
[TBL] [Abstract][Full Text] [Related]
11. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Gerhardt GA; Maloney RE
Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.
Butcher SP; Liptrot J; Aburthnott GW
Neurosci Lett; 1991 Jan; 122(2):245-8. PubMed ID: 1902922
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats.
Imperato A; Ramacci MT; Angelucci L
Neurosci Lett; 1989 Dec; 107(1-3):251-5. PubMed ID: 2616037
[TBL] [Abstract][Full Text] [Related]
14. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
Tomiyama K; Noguchi M; Koshikawa N; Kobayashi M
J Neurochem; 1993 May; 60(5):1690-5. PubMed ID: 8473891
[TBL] [Abstract][Full Text] [Related]
15. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.
Zetterström T; Sharp T; Collin AK; Ungerstedt U
Eur J Pharmacol; 1988 Apr; 148(3):327-34. PubMed ID: 3384000
[TBL] [Abstract][Full Text] [Related]
16. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
17. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
18. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites.
De Deurwaerdère P; Bonhomme N; Lucas G; Le Moal M; Spampinato U
J Neurochem; 1996 Jan; 66(1):210-5. PubMed ID: 8522956
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
[TBL] [Abstract][Full Text] [Related]
20. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum.
Tomiyama K; Koshikawa N; Funada K; Oka K; Kobayashi M
J Neurochem; 1995 Dec; 65(6):2790-5. PubMed ID: 7595579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
